Why the study?
It was unknown whether clinical outcomes of acute coronary syndrome patients with left main coronary artery disease vary between centers with and without on-site cardiac surgery.
Do clinical outcomes and revascularization strategies of ACS patients with left main disease vary between centers with and without on-site cardiac surgery?
Do clinical outcomes and revascularization strategies of ACS patients with left main disease vary between centers with and without on-site cardiac surgery?
Availability of on-site cardiac surgery influences revascularization strategies in ACS patients with left main disease, with higher PCI rates but also higher MACE in centers with on-site surgery, likely due to higher baseline risk.
Answers are grounded in this paper and cite their sources.
Selection bias likely explains higher PCI/MACE at surgical centers; leaves open causal effects of on-site surgery availability.
BACKGROUND: The treatment of left main coronary artery disease (LMCAD) in acute coronary syndrome patients is challenging in daily clinical practice. Therefore, the question arises whether the clinical outcomes of acute coronary syndrome (ACS) patients with LM disease vary between centers with and without cardiac surgery on site. METHODS: The study is a retrospective analysis of ACS patient outcomes using data from the PL-ACS registry, which is a Polish archive of ACS patients. The following analysis considered patients with LMCAD (n=4000) who were divided into two groups: those treated in the centers with the cardiac surgery department on site (CS group, n=427) and those without (non-CS group, n=3573). RESULTS: Patients with ACS in non-CS group more often were not qualified for revascularization than patients in CS group (11.7% in the CS group vs. 19.9% in the non-CS group, p<0.001), however, CABG was more common in non-CS group (18.7% in CS group vs. 25.7% in non-CS group, p<0.001). PCI, including angioplasty of LM, was more common in CS-group than non-CS group (38,6% vs. 30,3%, p<0.001). Among patients with ACS in CS group, major adverse cardiac events (MACE) were observed with greater frequency. CONCLUSIONS: Patients with LM disease admitted to the centers with CS initially had more risk factors for more intensive hospitalization compared to patients in centers without CS on-site. Clinical outcomes and treatment procedures may differ regarding the availability of CS on-site.
No takes yet. Share an insight, caveat, or question.
Śmiech et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: